Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Oldfield

Showing results (61-70 of 198) with videos related to

Pageof 20
Sort By:
Journal of the American Chemical Society|June 13, 2012
Are free radicals involved in IspH catalysis? An EPR and crystallographic investigationWeixue Wang, Ke Wang, Ingrid Span, et al.
Angewandte Chemie (International Ed. in English)|May 8, 2013
Isoprenoid biosynthesis: ferraoxetane or allyl anion mechanism for IspH catalysis?Jikun Li, Ke Wang, Tatyana I Smirnova, et al.
Chemical Biology & Drug Design|February 21, 2013
Farnesyl diphosphate synthase inhibitors from in silico screeningSteffen Lindert, Wei Zhu, Yi-Liang Liu, et al.
The Journal of Biological Chemistry|March 3, 2007
Bisphosphonates as inhibitors of Trypanosoma cruzi hexokinase: kinetic and metabolic studiesCarlos E Sanz-Rodríguez, Juan L Concepción, Sara Pekerar, et al.
Antimicrobial Agents and Chemotherapy|May 12, 2010
Lipophilic bisphosphonates are potent inhibitors of Plasmodium liver-stage growthAgam Prasad Singh, Yonghui Zhang, Joo-Hwan No, et al.
Journal of the American Chemical Society|May 13, 2014
Insights into the binding of pyridines to the iron-sulfur enzyme IspHIngrid Span, Ke Wang, Wolfgang Eisenreich, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2014
Taxodione and arenarone inhibit farnesyl diphosphate synthase by binding to the isopentenyl diphosphate siteYi-Liang Liu, Steffen Lindert, Wei Zhu, et al.
The Journal of Infectious Diseases|June 29, 2002
Radical cure of experimental cutaneous leishmaniasis by the bisphosphonate pamidronateNoris Rodriguez, Brian N Bailey, Michael B Martin, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 20, 2010
Tetra- to dodecanuclear oxomolybdate complexes with functionalized bisphosphonate ligands: activity in killing tumor cellsJean-Daniel Compain, Pierre Mialane, Jérôme Marrot, et al.
Proteins|April 30, 2008
Structures of a potent phenylalkyl bisphosphonate inhibitor bound to farnesyl and geranylgeranyl diphosphate synthasesRong Cao, Cammy K-M Chen, Rey-Ting Guo, et al.
Pageof 20

Showing results (61-70 of 198) with videos related to

Sort By:
Pageof 20
Journal of the American Chemical Society|June 13, 2012
Are free radicals involved in IspH catalysis? An EPR and crystallographic investigationWeixue Wang, Ke Wang, Ingrid Span, et al.
Angewandte Chemie (International Ed. in English)|May 8, 2013
Isoprenoid biosynthesis: ferraoxetane or allyl anion mechanism for IspH catalysis?Jikun Li, Ke Wang, Tatyana I Smirnova, et al.
Chemical Biology & Drug Design|February 21, 2013
Farnesyl diphosphate synthase inhibitors from in silico screeningSteffen Lindert, Wei Zhu, Yi-Liang Liu, et al.
The Journal of Biological Chemistry|March 3, 2007
Bisphosphonates as inhibitors of Trypanosoma cruzi hexokinase: kinetic and metabolic studiesCarlos E Sanz-Rodríguez, Juan L Concepción, Sara Pekerar, et al.
Antimicrobial Agents and Chemotherapy|May 12, 2010
Lipophilic bisphosphonates are potent inhibitors of Plasmodium liver-stage growthAgam Prasad Singh, Yonghui Zhang, Joo-Hwan No, et al.
Journal of the American Chemical Society|May 13, 2014
Insights into the binding of pyridines to the iron-sulfur enzyme IspHIngrid Span, Ke Wang, Wolfgang Eisenreich, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2014
Taxodione and arenarone inhibit farnesyl diphosphate synthase by binding to the isopentenyl diphosphate siteYi-Liang Liu, Steffen Lindert, Wei Zhu, et al.
The Journal of Infectious Diseases|June 29, 2002
Radical cure of experimental cutaneous leishmaniasis by the bisphosphonate pamidronateNoris Rodriguez, Brian N Bailey, Michael B Martin, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 20, 2010
Tetra- to dodecanuclear oxomolybdate complexes with functionalized bisphosphonate ligands: activity in killing tumor cellsJean-Daniel Compain, Pierre Mialane, Jérôme Marrot, et al.
Proteins|April 30, 2008
Structures of a potent phenylalkyl bisphosphonate inhibitor bound to farnesyl and geranylgeranyl diphosphate synthasesRong Cao, Cammy K-M Chen, Rey-Ting Guo, et al.
Pageof 20